172 related articles for article (PubMed ID: 21835316)
21. Coronary revascularization in patients with type 2 diabetes and results of the BARI 2D trial.
Sobel BE
Coron Artery Dis; 2010 May; 21(3):189-98. PubMed ID: 20308880
[TBL] [Abstract][Full Text] [Related]
22. [Revascularization in patients with type 2 diabetes and coronary artery disease: BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) Study Group].
Störk S; Ertl G; Nitschmann S
Internist (Berl); 2010 May; 51(5):674-6. PubMed ID: 20352177
[No Abstract] [Full Text] [Related]
23. Clinical implications of the BARI 2D and COURAGE trials: the evolving role of percutaneous coronary intervention.
Holper EM; Addo T
Coron Artery Dis; 2010 Nov; 21(7):397-401. PubMed ID: 20634692
[TBL] [Abstract][Full Text] [Related]
24. Hypotheses, design, and methods for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial.
Brooks MM; Frye RL; Genuth S; Detre KM; Nesto R; Sobel BE; Kelsey SF; Orchard TJ;
Am J Cardiol; 2006 Jun; 97(12A):9G-19G. PubMed ID: 16813734
[TBL] [Abstract][Full Text] [Related]
25. Presentation in patients with angiographically documented coronary artery disease and type II diabetes mellitus (from the BARI 2D Clinical Trial).
Krishnaswami A; Hardison R; Nesto RW; Sobel B;
Am J Cardiol; 2012 Jan; 109(1):36-41. PubMed ID: 21958742
[TBL] [Abstract][Full Text] [Related]
26. Favorable effects of insulin sensitizers pertinent to peripheral arterial disease in type 2 diabetes: results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
Althouse AD; Abbott JD; Sutton-Tyrrell K; Forker AD; Lombardero MS; Buitrón LV; Pena-Sing I; Tardif JC; Brooks MM;
Diabetes Care; 2013 Oct; 36(10):3269-75. PubMed ID: 23735723
[TBL] [Abstract][Full Text] [Related]
27. Relationship of extent of revascularization with angina at one year in the Bypass Angioplasty Revascularization Investigation (BARI).
Whitlow PL; Dimas AP; Bashore TM; Califf RM; Bourassa MG; Chaitman BR; Rosen AD; Kip KE; Stadius ML; Alderman EL
J Am Coll Cardiol; 1999 Nov; 34(6):1750-9. PubMed ID: 10577566
[TBL] [Abstract][Full Text] [Related]
28. Risk factors for incident peripheral arterial disease in type 2 diabetes: results from the Bypass Angioplasty Revascularization Investigation in type 2 Diabetes (BARI 2D) Trial.
Althouse AD; Abbott JD; Forker AD; Bertolet M; Barinas-Mitchell E; Thurston RC; Mulukutla S; Aboyans V; Brooks MM;
Diabetes Care; 2014; 37(5):1346-52. PubMed ID: 24595631
[TBL] [Abstract][Full Text] [Related]
29. Change in albuminuria and eGFR following insulin sensitization therapy versus insulin provision therapy in the BARI 2D study.
August P; Hardison RM; Hage FG; Marroquin OC; McGill JB; Rosenberg Y; Steffes M; Wall BM; Molitch M;
Clin J Am Soc Nephrol; 2014 Jan; 9(1):64-71. PubMed ID: 24178969
[TBL] [Abstract][Full Text] [Related]
30. Impact of treatment strategies on outcomes in patients with stable coronary artery disease and type 2 diabetes mellitus according to presenting angina severity: A pooled analysis of three federally-funded randomized trials.
Mancini GBJ; Boden WE; Brooks MM; Vlachos H; Chaitman BR; Frye R; Bittner V; Hartigan PM; Dagenais GR
Atherosclerosis; 2018 Oct; 277():186-194. PubMed ID: 29861270
[TBL] [Abstract][Full Text] [Related]
31. Impact of glycemic control strategies on the progression of diabetic peripheral neuropathy in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Cohort.
Pop-Busui R; Lu J; Brooks MM; Albert S; Althouse AD; Escobedo J; Green J; Palumbo P; Perkins BA; Whitehouse F; Jones TL;
Diabetes Care; 2013 Oct; 36(10):3208-15. PubMed ID: 23757426
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort.
Pop-Busui R; Lu J; Lopes N; Jones TL;
J Peripher Nerv Syst; 2009 Mar; 14(1):1-13. PubMed ID: 19335534
[TBL] [Abstract][Full Text] [Related]
33. Relation of severe coronary artery narrowing to insulin or thiazolidinedione use in patients with type 2 diabetes mellitus (from the Bypass Angioplasty Revascularization Investigation 2 Diabetes Study).
Pop-Busui R; Lombardero M; Lavis V; Forker A; Green J; Korytkowski M; Sobel BE; Jones TL;
Am J Cardiol; 2009 Jul; 104(1):52-8. PubMed ID: 19576321
[TBL] [Abstract][Full Text] [Related]
34. Effect of prompt revascularization on outcomes in diabetic patients with stable ischemic heart disease and previous myocardial infarction in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
Chung MJ; Novak E; Brown DL
Coron Artery Dis; 2017 Jun; 28(4):301-306. PubMed ID: 28346285
[TBL] [Abstract][Full Text] [Related]
35. Sex, clinical symptoms, and angiographic findings in patients with diabetes mellitus and coronary artery disease (from the Bypass Angioplasty Revascularization Investigation [BARI] 2 Diabetes trial).
Tamis-Holland JE; Lu J; Bittner V; Magee MF; Lopes N; Adler DS; Kip KE; Schwartz L; Groenewoud YA; Jacobs AK;
Am J Cardiol; 2011 Apr; 107(7):980-5. PubMed ID: 21276585
[TBL] [Abstract][Full Text] [Related]
36. Rationale, design, and methods for glycemic control in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial.
Magee MF; Isley WL;
Am J Cardiol; 2006 Jun; 97(12A):20G-30G. PubMed ID: 16813735
[TBL] [Abstract][Full Text] [Related]
37. Native coronary disease progression exceeds failed revascularization as cause of angina after five years in the Bypass Angioplasty Revascularization Investigation (BARI).
Alderman EL; Kip KE; Whitlow PL; Bashore T; Fortin D; Bourassa MG; Lesperance J; Schwartz L; Stadius M;
J Am Coll Cardiol; 2004 Aug; 44(4):766-74. PubMed ID: 15312856
[TBL] [Abstract][Full Text] [Related]
38. Response to letter regarding article, "rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial".
Bach RG; Brooks MM; Lombardero M; Genuth S; Donner TW; Garber A; Kennedy L; Monrad ES; Pop-Busui R; Kelsey SF; Frye RL;
Circulation; 2014 Apr; 129(16):e460-1. PubMed ID: 24753557
[No Abstract] [Full Text] [Related]
39. Strategies for glycemic control in nonobese and obese type 2 diabetic patients with coronary artery disease.
Tsujimoto T; Kajio H
Int J Cardiol; 2019 May; 282():1-6. PubMed ID: 30772014
[TBL] [Abstract][Full Text] [Related]
40. Do differences in repeat revascularization explain the antianginal benefits of bypass surgery versus percutaneous coronary intervention?: implications for future treatment comparisons.
Arnold SV; Magnuson EA; Wang K; Serruys PW; Kappetein AP; Mohr FW; Cohen DJ;
Circ Cardiovasc Qual Outcomes; 2012 May; 5(3):267-75. PubMed ID: 22496114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
